David Forsse
Overview
Explore the profile of David Forsse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lura N, Wagner-Larsen K, Ryste S, Fasmer K, Forsse D, Trovik J, et al.
Cancer Imaging
. 2025 Feb;
25(1):23.
PMID: 40022269
Pelvic MRI is essential for evaluating local and regional tumor extent in uterine cervical cancer (CC). Tumor microstructure captured by diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) markers may...
2.
Halle M, Hodneland E, Wagner-Larsen K, Lura N, Fasmer K, Berg H, et al.
Sci Rep
. 2024 May;
14(1):11339.
PMID: 38760387
Cervical cancer (CC) is a major global health problem with 570,000 new cases and 266,000 deaths annually. Prognosis is poor for advanced stage disease, and few effective treatments exist. Preoperative...
3.
Halle M, Bozickovic O, Forsse D, Wagner-Larsen K, Gold R, Lura N, et al.
Gynecol Oncol
. 2023 Dec;
181:110-117.
PMID: 38150835
Objective: Assess the added prognostic value of the updated International Federation of Gynecology and Obstetrics (FIGO) 2018 staging system, and to identify clinicopathological and radiological biomarkers for improved FIGO 2018...
4.
Eide A, Halle M, Lura N, Fasmer K, Wagner-Larsen K, Forsse D, et al.
Gynecol Oncol
. 2023 Jul;
176:62-68.
PMID: 37453220
Objective: The prognostic role of adiposity in uterine cervical cancer (CC) is largely unknown. Abdominal fat distribution may better reflect obesity than body mass index. This study aims to describe...
5.
Fasmer K, Gulati A, Dybvik J, Wagner-Larsen K, Lura N, Salvesen O, et al.
Eur Radiol
. 2022 Jun;
33(1):221-232.
PMID: 35763096
Objective: This study presents the diagnostic performance of four different preoperative imaging workups (IWs) for prediction of lymph node metastases (LNMs) in endometrial cancer (EC): pelvic MRI alone (IW1), MRI...
6.
Lura N, Wagner-Larsen K, Forsse D, Trovik J, Halle M, Bertelsen B, et al.
Insights Imaging
. 2022 Jun;
13(1):105.
PMID: 35715582
Background: Tumor size assessment by MRI is central for staging uterine cervical cancer. However, the optimal role of MRI-derived tumor measurements for prognostication is still unclear. Material And Methods: This...
7.
Wagner-Larsen K, Lura N, Salvesen O, Halle M, Forsse D, Trovik J, et al.
Eur Radiol
. 2022 Mar;
32(9):6444-6455.
PMID: 35332408
Objectives: To evaluate the interobserver agreement for MRI-based 2018 International Federation of Gynecology and Obstetrics (FIGO) staging parameters in patients with cervical cancer and assess the prognostic value of these...
8.
Kasius J, Pijnenborg J, Lindemann K, Forsse D, van Zwol J, Kristensen G, et al.
Cancers (Basel)
. 2021 Nov;
13(22).
PMID: 34831000
Endometrial cancer (EC) is the most common gynaecologic malignancy in developed countries. The main challenge in EC management is to correctly estimate the risk of metastases at diagnosis and the...
9.
Halle M, Munk A, Engesaeter B, Akbari S, Frafjord A, Hoivik E, et al.
Cancers (Basel)
. 2021 Nov;
13(22).
PMID: 34830895
The purpose of this study was to establish a gene signature that may predict CIN3 regression and that may aid in selecting patients who may safely refrain from conization. Oncomine...
10.
Forsse D, Barbero M, Werner H, Woie K, Nordskar N, Nilsen E, et al.
Am J Obstet Gynecol
. 2021 Aug;
226(1):90.e1-90.e20.
PMID: 34400137
Background: Most patients with endometrial cancer with localized disease are effectively treated and survive for a long time. The primary treatment is hysterectomy, to which surgical staging procedures may be...